Posts

Hims & Hers Acquires Australian Digital Health Company Eucalyptus for Up to $1.15 Billion

Hims & Hers agreed to acquire Australian digital health company Eucalyptus in a deal valued at up to $1.15 billion, with $240 million paid upfront 1 2 The acquisition provides Hims & Hers with entry into Australia and Japan, while expanding its presence in the UK, Germany, and Canada 1 2 Eucalyptus operates direct-to-consumer healthcare brands including Juniper (weight-loss platform), Pilot (men's health), and Compound, serving approximately 775,000 customers with annualized revenues around $450 million 2 The deal is expected to close mid-year 2026, with the remainder of the valuation tied to guaranteed payments over 18 months and performance-based earnouts through early 2029 2 The acquisition signals Hims & Hers' pivot toward global expansion amid mounting regulatory scrutiny and legal challenges in the United States related to compounded GLP-1 medications 2 This acquisition follows Hims & Hers' 2024 purchases of UK digital health provider Zava an...

FDA Adopts Single Pivotal Trial as New Default for Drug Approvals

Johnson & Johnson Announces Over $1 Billion Investment in Pennsylvania Cell Therapy Facility

FDA Reverses Course on Moderna's mRNA Flu Vaccine Application After Initial Rejection

Novartis Partners with Unnatural Products on Up to $1.8B Macrocyclic Peptide Deal for Cardiovascular Therapeutics

Korsana Biosciences Launches with $175M to Develop Brain-Penetrant Alzheimer's Antibody

Eli Lilly Reports Positive TOGETHER-PsO Trial Results for Taltz and Zepbound Combination in Psoriasis and Obesity

Charles River Laboratories Announces Executive Appointments

Nation's Leading Oncology and Value-Based Care Experts Join Daymark Health's Clinical Advisory Board

Eli Lilly Licenses CSL's Clazakizumab IL-6 Antibody for $100 Million

FDA Reverses Course and Agrees to Review Moderna's mRNA Flu Vaccine

Nimbus Therapeutics Presents SIK2 Inhibitor Data at ECCO Congress 2026

Texas Tech Researchers Awarded NIH Grant to Advance Wearable Heart Monitoring Devices